ARCHIMED

Agatha Inc. is a software solution provider focused on the healthcare and life sciences sectors, offering a cloud-based content management platform tailored for hospitals, pharmaceutical companies, and clinical research organizations. Founded in 2015 and headquartered in Tokyo, Japan, Agatha's platform facilitates the management of various quality and clinical documentation processes, including deviations, corrective and preventive actions (CAPA), complaints, audits, and change control. It also streamlines the authoring, review, and distribution of standard operating procedures (SOPs) and manages regulatory documentation in accordance with established models. With features such as immediate availability, e-training, compliance support, and private cloud services, Agatha aims to optimize the workflow and quality management in clinical research and trials for its clients.

BioVendor Group is a provider of products and services in the fields of biomedical research, clinical diagnostics, veterinary diagnostics, and food analysis. Through strategic partnerships with companies like Test Line Clinical Diagnostics, BioVendor Instruments, Immunolab, ViennaLab Diagnostics, and Genetrac, the company has built a comprehensive and quality-focused portfolio. This collaboration allows BioVendor Group to cater to professionals in various industries, offering a range of solutions to meet their specific needs and requirements.

Irrimax Corporation specializes in the development, clinical research, manufacturing, and commercialization of medical technologies aimed at treating and preventing infections. Founded in 2003 and based in Lawrenceville, Georgia, the company offers Irrisept, a wound debridement and cleansing system designed to effectively remove bacteria, particulate matter, and debris from wounds while preserving underlying tissues. Irrimax's products are distributed through various suppliers and distributors across the United States. The company is committed to improving patient outcomes, enhancing the safety of healthcare professionals, and reducing healthcare costs. Irrimax operates as a subsidiary of Innovation Technologies, Inc.

WiQo is a professional manufacturer of dermocosmetic products and medical devices headquartered in Trieste, Italy. The company specializes in the development of aesthetic medicines and offers a range of medical products and cosmeceuticals designed to enhance beauty. Among its notable innovations is the patent-protected PRX-T33, a chemical-free stimulation treatment that provides effective results without the use of harsh chemicals. WiQo focuses on combining scientific research with practical applications to meet the needs of its customers in the beauty and healthcare sectors.

Title21 Health Solutions is a user-centric and innovative technology that provides fully-integrated and flexible solutions to health science organizations to increase operational efficiency, close compliance gaps, and improve patient care and outcomes. Since 2001, Title21 has created adaptable software products targeted to the unique needs of firms in the regulated life science industry. The flexible and user-friendly technology that made Title21 the go-to quality management platform and is now available to fully-automate cellular therapy environments.

Corealis Pharma is a contract service provider specializing in formulation and process development for pharmaceutical and biotech companies. The company focuses on the manufacturing of small-scale clinical trial materials and the packaging of solid dosage forms, including tablets, capsules, and granules. Corealis Pharma offers a comprehensive range of services, including active pharmaceutical ingredient (API) characterization, salt selection, pre-formulation, and analytical method development. Additionally, the company provides stability storage and testing, technical transfer, scale-up, cGMP manufacturing, and packaging for phase I and II clinical trial materials, along with dossier support. By aligning its efforts with client needs, Corealis Pharma ensures that the development of drugs meets industry standards and requirements.

Natus Medical is a prominent provider of healthcare products focused on the screening, diagnosis, treatment, and monitoring of various medical conditions. The company specializes in products for newborn care, hearing impairments, neurological dysfunctions, epilepsy, sleep disorders, and balance and mobility disorders. Natus offers a range of non-invasive medical instruments and disposables, including computerized neurodiagnostic systems for audiology and neurology, as well as newborn care devices such as hearing screening systems, phototherapy equipment for jaundice, head-cooling products for brain injury treatment, and incubators to create optimal environments for newborns. Additionally, Natus provides software solutions for managing and tracking disorders, serving public health laboratories and enhancing the accuracy of patient diagnoses in healthcare settings.

Groupe CARSO is a specialized provider of environmental and agrifood analytical services, established in 1992 through a partnership between Neptune Technologies and the CNRS. Initially focused on analyzing dioxins using high-resolution mass spectrometry, the company expanded its capabilities by acquiring water and asbestos analysis operations from the Institut Pasteur in Lyon in 1997. Throughout the 2000s, CARSO enhanced its analytical expertise through strategic acquisitions of various laboratories, including those specializing in radioactivity and ecotoxicology. The company offers a comprehensive suite of services, including bioassays that utilize non-invasive pollutant shrimp to assess chemical contamination and toxicity in water and aquatic environments. This diverse range of analytical services positions Groupe CARSO as a key player in environmental monitoring and assessment.

Cardioline is a Milan-based company that designs and manufactures advanced medical equipment aimed at enhancing global healthcare. The company specializes in creating diagnostic and therapeutic devices such as electrocardiographs, ambulatory monitors, and telemedicine applications. By providing reliable tools and medical support, Cardioline enables physicians to improve patient care and treatment outcomes.

Cube Biotech specializes in innovative products and solutions for membrane protein research, which is critical for pharmaceutical development. The company operates on a dual business model comprising a service unit focused on the structural analysis of membrane proteins and a product unit that generates consistent revenue. Membrane proteins are vital in the study of various diseases and are key targets in drug discovery, yet their structural analysis remains a significant challenge. Cube Biotech offers a comprehensive range of products, including nanodiscs, purification resins, magnetic beads, protein purification matrices, cell-free lysates, and ultrapure detergents, which facilitate access to essential membrane protein structure information. The company's unique technology positions it advantageously within the market, providing valuable services and products to customers in the pharmaceutical and biotechnological sectors, as well as academia. With over 40 years of combined experience in membrane protein expression, purification, and crystallization, Cube Biotech is well-equipped to advance research in this crucial area, highlighted by the recognition of membrane protein research with the 2012 Nobel Prize in Chemistry.

Xpress Biologics operates as a contract manufacturing company focused on pre-clinical productions. It offers a comprehensive range of services, including the design of microbial expression systems, the development of upstream and downstream processes, and the establishment of quality controls for the production of recombinant proteins, antibody fragments, and plasmid DNA. By providing these capabilities, Xpress Biologics supports the vaccine, therapeutic, and diagnostic markets in executing and managing clinical trials effectively. The company's approach positions it as a one-stop shop for clients seeking to advance their biopharmaceutical developments.

Suanfarma Biotech engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. Suanfarma Biotech also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, it invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. Suanfarma Biotech serves customers in Spain and internationally. It began operation in 1993, with its headquarters in Alcobendas in Spain and locations in Phoenix in Arizona, Fair Lawn in New Jersey, Naucalpan de Juárez in Mexico; Bogotá in Colombia, Caracas in Venezuela, Sao Paulo in Brazil, Buenos Aires in Argentina, Santiago in Chile, Madrid and Barcelona in Spain, Fitbourg in Switzerland, Dubai in the United Arab Emirates, Navi Mumbai in India, and Shanghai in China.

Stragen is a global player in the development, registration, and distribution of Generic drugs, Consumer Health products, and Original drugs.

Ad-Tech Medical Instrument Corporation is a leading manufacturer and distributor of intra-cranial monitoring devices, particularly electrodes used in the treatment of intractable epilepsy and related neurosurgical instrumentation. The company's products are designed for long-term EEG monitoring, mapping, SEEG, and brain stimulation for individuals with epilepsy and other neurological disorders. Ad-Tech offers a range of proprietary electrode designs, including subdural strip and grid electrodes, depth electrodes, and cranial nerve electrodes, along with accessory placement devices and brain biopsy needles. These devices are characterized by advanced materials, ease of use, and innovative connection systems, ensuring high safety and effectiveness in clinical applications. With over 30 years of experience, Ad-Tech has established a reputation for quality-driven manufacturing and innovative designs, including pioneering tunneling techniques to reduce the risk of cerebrospinal fluid leakage. The company's depth electrode design is widely regarded as the gold standard in the industry. Continuous innovation has allowed Ad-Tech to expand its product offerings and maintain a strong position in the neuro-monitoring and neurosurgery markets.

NAMSA is a medical research organization that offers regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. They provide strategic guidance and tactical support throughout the product development process to help clients bring their medical products to market in major global markets. NAMSA prioritizes quality and efficiency, ensuring that clients have a smart strategy in place from the beginning to avoid setbacks. Their expertise and insight make them a trusted partner for navigating the complex landscape of medical product commercialization.

ActiGraph, established in 2004 and based in Pensacola, Florida, specializes in developing and providing medical-grade wearable technology for objective, continuous measurement of physical activity, sleep, and mobility. The company offers a range of activity monitors, software, and data management solutions, including the ActiGraph GT9X Link, wGT3X-BT, and the CentrePoint platform. ActiGraph's technology is designed to facilitate data collection and analysis in research studies and clinical trials, aiding in the understanding and management of conditions such as cardiovascular disease and sleep disorders. The company aims to improve global health by delivering accurate, innovative, and cost-effective solutions to the scientific, pharmaceutical, healthcare, and wellness communities.

Direct Healthcare Group Ltd. is a manufacturer and supplier of healthcare accessories and pressure area solutions, focusing on products designed to prevent medical issues such as pressure sores. The company offers a diverse range of products, including hybrid and static mattresses, cushions, bariatric beds, and residential homecare beds, under the brands DYNA-FORM, KIRTON, and NIGHTINGALE. Additionally, it provides wheelchairs, recliners, and scale systems. Beyond product offerings, Direct Healthcare Group also delivers services such as equipment auditing, collection and decontamination, infection control, and equipment rental and leasing. The company serves various sectors, including community healthcare, nursing homes, and wheelchair services, both in the United Kingdom and internationally. Established in 2004 and based in Caerphilly, United Kingdom, Direct Healthcare Group has an additional office in Webley, Australia. It was formerly known as Direct Healthcare Services Ltd. before rebranding in November 2017.

EuroLyser Diagnostica GmbH, based in Salzburg, Austria, specializes in the development, manufacturing, and distribution of medical and veterinary diagnostic products. The company focuses on point-of-care testing devices and kits, aiming to enhance the speed and accuracy of medical diagnostics. By providing instruments and test kits designed for use in doctors' practices and hospital emergency rooms, EuroLyser enables physicians to make quicker decisions, independent of laboratory results. This approach not only streamlines the diagnostic process but also facilitates timely treatment, which is essential for effective healthcare management.

Diesse is an Italian developer of innovative in vitro diagnostic (‘IVD’) systems for the diagnosis of infectious and autoimmune diseases.

Bomi Group is a logistics service provider specializing in the healthcare sector. It offers a range of solutions designed to facilitate the distribution of healthcare products on a global scale. The company provides transport, warehousing, and supply chain management services tailored to the needs of various healthcare entities, including pharmaceutical manufacturers, medical equipment suppliers, hospitals, testing laboratories, and outpatient service providers. By focusing on the specific requirements of the diagnostic and medical fields, Bomi Group aims to enhance the efficiency and reliability of healthcare logistics.

Clean Cells SAS, based in Boufféré, France, provides essential services for the biopharmaceutical industry, focusing on quality control, safety testing, and product development. Founded in 2000, the company specializes in viral and biological safety testing for various biopharmaceuticals, including recombinant proteins, therapeutic antibodies, vaccines, and cell and gene therapies. Clean Cells also produces GMP-grade cell and virus banks and offers secure storage solutions in liquid and gaseous nitrogen. Additionally, the company engages in biobanking and custom-made tests required by international regulatory bodies to ensure the safety of biological products throughout production. With a commitment to advancing personalized medicine, Clean Cells seeks to play a significant role in developing new therapies, including innovative experimental drugs like cell therapy products and therapeutic phages.

Provepharm Life Solutions SA is a life sciences company based in Marseille, France, specializing in contract research and development services for small molecules and therapeutic peptides. Founded in 1998, the company focuses on the development, manufacturing, and marketing of pharmaceutical products and active ingredients. A key offering is pharmacopoeial grade methylene blue, a versatile compound utilized in various human health applications, including as an antidote for methemoglobinemia, a mild urinary antiseptic, and a topical antiseptic. The company also addresses animal health needs, providing solutions for toxicosis and aquaculture. Methylene blue serves additional roles as a laboratory dye, indicator, and diagnostic aid in surgical procedures. Provepharm Life Solutions aims to lead in the life sciences sector through its innovative approach, known as Molecule Vitalization, and offers a range of research and manufacturing services to advance health solutions.

Soest Medical Group, based in Soest, the Netherlands, specializes in the development and manufacturing of self-adhesive medical supplies, primarily used to secure protective drapes to patients' skin during surgical procedures. Founded in 1990, the company works closely with hospitals and universities to research and improve its product offerings. Soest Medical Group provides both reusable and disposable options, allowing clients to select from a diverse range of products tailored to meet the needs of medical care institutions. The company prioritizes customer connection and collaboration in optimizing its standard and customized solutions.

Fytexia is a supplier of innovative and scientifically proven natural ingredients for the international nutraceutical industry, located in the South of France along the Mediterranean Sea. The company specializes in diet polyphenols, antioxidants, and nutritional supplements, aiming to provide health benefits linked to the Mediterranean diet. By focusing on the development of products that help reduce risk factors for non-communicable diseases, Fytexia serves clients in the food supplement sector with solutions that are both effective and clinically validated.

Polyplus-transfection SA is a biotechnology company based in Illkirch-Graffenstaden, France, specializing in the development and sale of solutions for nucleic acid delivery across research, bioproduction, and therapeutic applications. Established in 2001 and ISO 9001-certified since 2002, the company offers a diverse range of proprietary reagents for the transfection of genes, oligonucleotides, and siRNA. These products facilitate various applications including enhanced in vivo delivery, molecular biology, diagnostics, gene expression, RNA interference, and protein production. Polyplus-transfection's reagents are increasingly utilized in clinical trials globally, supported by a network of distributors. The company also holds a comprehensive portfolio of patents and licenses, featuring innovative methods for therapeutic siRNA delivery.

Micromed is an Italian company that specializes in the manufacturing of medical devices designed for neurophysiology diagnostics. The company produces a comprehensive range of electro medical devices that monitor the electrical activity of the brain, muscles, and nerves. Their product lineup includes systems for long-term monitoring (LTM), intensive care unit (ICU) applications, electroencephalograms (EEG), electromyograms (EMG), and polysomnography (PSG). This extensive offering allows clients to access a variety of electromedical devices tailored for neurology diagnostics.

Herb's International Service is a French leader in natural health ingredients. A team of 25 people who are passionate with botanicals. An agile company expert in sourcing herbal raw material. Sourcing means genuine quality, traceability, environment and ethical practices. We are audited each year by Ecocert and we have been granted the excellence label as a responsible company. We believe in partnership and work closely with our farmers, contract manufacturers to deliver the best ingredients to our customers. We design many type of natural ingredients using our raw material and we share our expertise with you. Service is key for us. We are dedicated to your projects.

Vita Health Group Limited is a healthcare organization based in Bury St. Edmunds, United Kingdom, that specializes in injury management and rehabilitation services for the industry and insurance sectors. Founded in 1987, the company provides a comprehensive range of services including preventative care, occupational health, physiotherapy, psychological therapy, case management, and functional restoration. Vita Health Group employs a biopsychosocial approach to address both physical and mental health conditions, focusing particularly on musculoskeletal disorders. By integrating workplace involvement into the recovery process, the company effectively reduces absenteeism and demonstrates significant financial savings for its clients, which include insurers, employers, and government entities. With its emphasis on delivering end-to-end solutions, Vita Health Group has established itself as a leader in occupational treatment programs and workplace wellness initiatives.

Deallus is a global life sciences management consultancy that provides strategic intelligence consulting services specifically tailored for the life sciences sector. The company offers comprehensive advisory services covering various aspects, including product introduction and sustaining corporate innovation. By equipping clients with the necessary insights and strategies, Deallus enables them to make informed decisions and secure competitive advantages in a challenging marketplace.

Centri Dentistici Primo operates a network of dental clinics across Italy, providing a comprehensive range of dental services. Their offerings include hygiene and conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, allowing them to cater to a diverse clientele of all ages. The company emphasizes trust and transparency in its patient relationships, ensuring that care is delivered with seriousness and clarity. This commitment to personalized treatment underscores their approach to dentistry, aiming to foster sincere connections between staff and patients while addressing a variety of dental needs.

Centri Dentistici Primo operates a network of dental clinics across Italy, providing a comprehensive range of dental services. Their offerings include hygiene and conservation, implantology, prosthetics, orthodontics, endodontics, and periodontology, allowing them to cater to a diverse clientele of all ages. The company emphasizes trust and transparency in its patient relationships, ensuring that care is delivered with seriousness and clarity. This commitment to personalized treatment underscores their approach to dentistry, aiming to foster sincere connections between staff and patients while addressing a variety of dental needs.

Citieffe s.r.l., established in 1962 and headquartered in Calderara di Reno, Italy, specializes in the design and manufacture of surgical instruments. The company is recognized for developing innovative and patented medical products, including intramedullary nails designed for trochanter fractures and advanced external fixation devices focused on reconstruction. Through its commitment to quality and innovation, Citieffe s.r.l. plays a significant role in the healthcare sector, providing essential tools that enhance surgical procedures.